Similar articles for PMID: 22430005

Year	Number of Results
2001	1
2003	1
2004	4
2005	9
2006	10
2007	10
2008	8
2009	5
2010	5
2011	6
2012	6
2013	5
2014	1
2019	1
2021	1
2022	2
2023	1
2024	0

1

[The potential use of cannabidiol in the therapy of metabolic syndrome].

Kleiner D, Ditrói K. Kleiner D, et al. Orv Hetil. 2012 Apr 1;153(13):499-504. doi: 10.1556/OH.2012.29308. Orv Hetil. 2012. PMID: 22430005 Review. Hungarian.

2

[Pharmacological therapy of obesity].

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R. Pagotto U, et al. G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. G Ital Cardiol (Rome). 2008. PMID: 18773755 Italian.

3

[A drug for therapy of obesity: really only life style? (interview by Dirk Einecke)].

Wirth A. Wirth A. MMW Fortschr Med. 2006 Nov 16;148(46):17. MMW Fortschr Med. 2006. PMID: 17615781 German. No abstract available.

4

Rimonabant redux and strategies to improve the future outlook of CB1 receptor neutral-antagonist/inverse-agonist therapies.

Ward SJ, Raffa RB. Ward SJ, et al. Obesity (Silver Spring). 2011 Jul;19(7):1325-34. doi: 10.1038/oby.2011.69. Epub 2011 Apr 7. Obesity (Silver Spring). 2011. PMID: 21475141 Free article. Review. No abstract available.

5

Multiple sclerosis following treatment with a cannabinoid receptor-1 antagonist.

van Oosten BW, Killestein J, Mathus-Vliegen EM, Polman CH. van Oosten BW, et al. Mult Scler. 2004 Jun;10(3):330-1. doi: 10.1191/1352458504ms1044oa. Mult Scler. 2004. PMID: 15222701

6

The safety of obesity drugs.

Van Gaal LF, Scheen AJ, Formiguera X. Van Gaal LF, et al. Expert Opin Drug Saf. 2007 Sep;6(5):475-6; author reply 477-8. doi: 10.1517/14740338.6.5.475. Expert Opin Drug Saf. 2007. PMID: 17877434 No abstract available.

7

Cannabinoid type 1 receptor blockade induces transdifferentiation towards a brown fat phenotype in white adipocytes.

Perwitz N, Wenzel J, Wagner I, Büning J, Drenckhan M, Zarse K, Ristow M, Lilienthal W, Lehnert H, Klein J. Perwitz N, et al. Diabetes Obes Metab. 2010 Feb;12(2):158-66. doi: 10.1111/j.1463-1326.2009.01133.x. Epub 2009 Nov 5. Diabetes Obes Metab. 2010. PMID: 19895638

8

Antagonism of type-1 cannabinoid receptors: good for obesity, but is it safe for fertility?

Maccarrone M, Wang H, Dey SK. Maccarrone M, et al. Clin Endocrinol (Oxf). 2007 Mar;66(3):456-7. doi: 10.1111/j.1365-2265.2007.02760.x. Clin Endocrinol (Oxf). 2007. PMID: 17302885 No abstract available.

9

Metabolic syndrome treatment strategies.

Fujioka K. Fujioka K. Pharmacotherapy. 2006 Dec;26(12 Pt 2):222S-226S. doi: 10.1592/phco.26.12part2.222S. Pharmacotherapy. 2006. PMID: 17125449 Review.

10

[Positive influence on cardiovascular risk factor by blocking the endocannabinoid system].

Chatterjee T, Ritz A, Ince H, Nienaber ChA, Rehders TC. Chatterjee T, et al. Praxis (Bern 1994). 2008 May 28;97(11):613-21. doi: 10.1024/1661-8157.97.11.613. Praxis (Bern 1994). 2008. PMID: 18592956 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

70 results

Results by year